The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
about
Therapeutic interventions for Burkitt lymphoma in childrenIonizing radiation and chronic lymphocytic leukemia.Mismatch repair gene expression in malignant lymphoproliferative disorders of B-cell originPhosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitorsPrimary extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type in the CNS.Parallel gene expression profiling of mantle cell lymphoma - how do we transform 'omics data into clinical practiceMultiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia.Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineageAcute myelomonocytic leukaemia with short-term spontaneous remission in a cat.A single center experience: rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchial-associated lymphoid tissue lymphoma.Discrepancies in Lymphoma Diagnosis Over the Years: A 13-Year Experience in a Tertiary CenterPediatric pulmonary Hodgkin lymphoma: analysis of 10 years data from a single center.microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphomaCytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemiaAberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.Fine-needle aspiration biopsy in the diagnosis and classification of primary and recurrent lymphoma: a retrospective analysis of the utility of cytomorphology and flow cytometry.Is myelodysplastic related acute myelogenous leukemia a distinct entity from de novo acute myelogenous leukemia? Potential for targeted therapies.FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma.Ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases.The new World Health Organization classification of lymphomas: the past, the present and the future.Nosocomial infection in adult admissions with hematological malignancies originating from different lineages: a prospective observational study.Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.Differentiating primary pancreatic lymphoma from adenocarcinoma using endoscopic ultrasound characteristics and flow cytometry: A case-control study.Oral signs of acute leukemia for early detection.Oral manifestations of acute myelomonocytic leukemia: a case report and review of the classification of leukemias.Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.Molecular cytogenetic characterization of Sézary syndrome.Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries.A single-centre experience of post-renal transplant lymphoproliferative disorder.A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies.Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas.S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phaseTransferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas.Dietary pattern and risk of hodgkin lymphoma in a population-based case-control study.Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphomaLymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative eventsRare lymphoid malignancies of the breast: report of two cases illustrating potential diagnostic techniques
P2860
Q24235495-0BEE6AC9-A8B9-49C4-B614-5E5A43000C9DQ24534890-D8224037-7FF0-41A4-B7C6-C97EAB1F7C31Q28216989-C6538C28-038C-4E63-81A2-F564F1C52E93Q30620482-B6B7696C-9D2A-4D2C-9E14-889D0AA4602AQ30663444-A8E4F532-B465-489B-A0BF-323F46B67A58Q31164228-A35481B9-2723-46A7-98D5-C76E26078E9CQ33362760-D3BC4B77-633D-4B9A-8267-0A35AD3E4C82Q33365711-8D08260B-9AB5-4124-8408-EE0079A6907FQ33366973-F1C7DE56-6034-4305-A488-96777984372CQ33379713-B21D1C9E-98A5-4E0C-A1D2-F1DFA4518CB4Q33639281-5A25F8C6-C37E-467D-87C1-99D789146FA1Q33747827-A37BC11E-16DB-4099-8FEE-9554E0C78816Q33767692-8B89DAFE-6222-418B-AB92-68F2EBDB8A1FQ33780259-C390D4A0-1318-425E-8FC5-FA2FE04FA5F1Q33910990-9AB026BC-72D0-48ED-ACA3-7FBF9D119CE2Q34047994-C2E39001-8155-4ACC-A9E8-F6F317ABF45FQ34166581-7EE9C0CC-C9AB-45F3-9E00-AD846C627F7EQ34250987-95323871-BF67-4D20-9F00-6E745872B686Q34265233-460D1563-E48F-4E6C-BBBC-B719800AB26CQ34269804-4E7F45A8-2963-4715-96A2-C8A70C8C8562Q34436783-A8A1F035-90B3-48F9-A784-E1EC9846C309Q34469138-5506E4DE-FD31-4A8D-93FD-005356179211Q34557550-81DD554C-11E6-4828-A08C-41124E550AECQ34579668-AA98E5D6-EBC1-4FBD-914B-96D4006D1886Q34586264-E171F1D1-9F89-4714-942C-2B980404AC19Q34667391-497A5AE3-D7D9-4FC3-82B4-D5412052278EQ34706520-087B6CE4-9360-4AEB-BC55-2B90E51D689BQ34890475-129A755F-B851-4865-87E7-370F34955C39Q35056476-0825626E-6764-4AC9-A2B6-214FE33ED121Q35076617-D684DF34-9B12-4C2C-9BC6-41E58351557CQ35122814-0F150D70-8868-4B06-AA0D-F90CD2431F9DQ35134208-C5F41357-5ED3-41A3-87D2-9393F2008A57Q35166856-DDE3D60B-093E-4524-BDD2-13A412B247B9Q35587570-B713732D-B82C-4301-9393-733F9595138BQ35788983-19242F22-F93B-4181-8718-93EE06433076Q35881523-A809639E-FC6D-4EB2-8C5B-52DA414EDC94Q36003614-E95667E4-53EF-4B57-890D-EBBD914D6066Q36051526-21B3258A-6B9F-4BEB-A7D2-F5C0DE3C49D1Q36190436-16DCDB07-CCB8-4C24-8E72-990AB2C5EC28Q36568075-D75BE432-7A76-4DD5-838D-725087FBE0B7
P2860
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
The World Health Organization ...... ouse, Virginia, November 1997.
@en
The World Health Organization ...... ouse, Virginia, November 1997.
@nl
type
label
The World Health Organization ...... ouse, Virginia, November 1997.
@en
The World Health Organization ...... ouse, Virginia, November 1997.
@nl
prefLabel
The World Health Organization ...... ouse, Virginia, November 1997.
@en
The World Health Organization ...... ouse, Virginia, November 1997.
@nl
P2093
P1433
P1476
The World Health Organization ...... ouse, Virginia, November 1997.
@en
P2093
Flandrin G
Muller-Hermelink HK
Vardiman J
P2888
P304
P356
10.1038/MODPATHOL.3880035
P577
2000-02-01T00:00:00Z